United Kingdom Metered Dose Inhaler Devices Market Outlook to 2023

2017-07-10
Price :
Published : Jul-2017
No. of Pages : 48
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Metered Dose Inhaler Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 5
3 Metered Dose Inhaler Devices Market, United Kingdom 6
3.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016 6
3.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023 8
3.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016 9
3.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023 10
3.5 Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), 2009-2023 11
3.6 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 12
3.7 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 13
4 Overview of Key Companies in United Kingdom, Metered Dose Inhaler Devices Market 15
4.1 GlaxoSmithKline Plc 15
4.1.1 Company Overview 15
4.2 AstraZeneca Plc 15
4.2.1 Company Overview 15
4.3 Boehringer Ingelheim GmbH 15
4.3.1 Company Overview 15
4.4 Pfizer Inc 16
4.4.1 Company Overview 16
4.5 Merck & Co Inc 16
4.5.1 Company Overview 16
5 Financial Deals Landscape 17
5.1 Debt Offerings 17
5.1.1 Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 17
6 Recent Developments 18
6.1 Corporate Communications 18
6.1.1 May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 18
6.1.2 Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 18
6.1.3 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 19
6.1.4 Mar 06, 2017: Vectura Group: Board Change 20
6.1.5 Dec 14, 2016: Consort Medical: Directorate Change 20
6.1.6 Nov 25, 2016: Consort Medical: CFO Appointment 21
6.1.7 Aug 17, 2016: Consort Medical Announces Directorate Change 21
6.1.8 Jul 08, 2016: Dr John Brown, Non-Executive Director, confirms date to step down 21
6.2 Financial Announcements 22
6.2.1 Jun 15, 2017: Consort Medical: Full year results 22
6.2.2 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 22
6.2.3 May 10, 2017: Mylan Reports First Quarter 2017 Results 24
6.2.4 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 26
6.2.5 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics' Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 26
6.2.6 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 29
6.2.7 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 30
6.2.8 Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 31
6.2.9 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 33
6.2.10 Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 34
6.2.11 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 38
6.3 Other Significant Developments 41
6.3.1 Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products 41
6.3.2 Jan 11, 2017: Vectura Group: Pre-close update 41
6.3.3 Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 42
7 Appendix 44
7.1 Research Methodology 45
7.1.1 Coverage 45
7.1.2 Secondary Research 45
7.1.3 Primary Research 46
7.1.4 Company Share Analysis 46
7.1.5 Distribution Share Analysis 46
7.1.6 Benchmarking 47
7.2 GlobalData Consulting 47
7.3 Contact Us 48
7.4 Disclaimer 48

1.1 List of Tables
Table 1: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 6
Table 2: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 8
Table 3: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 9
Table 4: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 10
Table 5: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016 11
Table 6: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023 11
Table 7: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 12
Table 8: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 14
Table 9: Mylan Raises USD551.6 Million in Public Offering of Bonds Due 2020 17

1.2 List of Figures
Figure 1: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 6
Figure 2: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 8
Figure 3: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 9
Figure 4: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 10
Figure 5: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016 13
Filed in: Medical Device
Publisher : GlobalData